Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mediator complex subunit 7 (MED7) is a protein-coding gene product that serves as a component of the Mediator complex, a multi-protein assembly critical for regulating transcription by RNA polymerase II in all eukaryotes[2][1][4]. The Mediator complex acts as a hub, integrating regulatory signals from gene-specific transcription factors and conveying them to the basal transcription apparatus[2]. MED7 specifically participates in the 'middle module' of Mediator and forms part of a structurally distinctive submodule, with roles in activated transcription, positive gene regulation, and control of specific metabolic, stress response, and DNA maintenance processes[1]. MED7 does not exhibit catalytic activity and is not a typical drug target, but its functional disruption can lead to disease phenotypes, emphasizing its essential role in transcriptional regulation[2][1][4].
Not applicable. No approved drugs act via modulating MED7 directly (the mechanism would theoretically be modulation of Mediator complex function or transcriptional regulation if such agents existed).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mediator complex subunit 7 (MED7).